The largest database of trusted experimental protocols
> Procedures > Diagnostic Procedure > Multiparametric Magnetic Resonance Imaging

Multiparametric Magnetic Resonance Imaging

Multiparametric Magnetic Resonance Imaging (mpMRI) is a advanced imaging technique that combines multiple MRI modalities to provide comprehensive assessment of anatomical and functional characteristics of tissues.
This non-invasive approach enables detailed evaluation of parameters such as proton density, T1 and T2 relaxation times, diffusion, perfusion, and metabolic information. mpMRI has emerged as a powerful tool for diagnosing and monitoring a variety of medical conditions, including cancer, neurodegenerative disorders, and cardiovascular disease.
By integrating complementary MRI data, mpMRI can enhance diagnostic accuracy, improve treatment planning, and facilitate earlier disease detectioin.
This versatile imaging method continues to evolve, offering new insights and opportunities for clinicians and reserchers to advance patient care.

Most cited protocols related to «Multiparametric Magnetic Resonance Imaging»

A Delphi consensus process was undertaken to formulate recommendations regarding three different areas in the diagnostic MRI pathway of PCa: (1) image quality assessment of mpMRI; (2) interpretation and reporting of mpMRI; and (3) reader experience and training requirements. The Delphi method is a technique of structured and systematic information gathering from experts on a specific topic using a series of questionnaires [13 (link)]. In this study, the diagnostic role of mpMRI in biopsy-naïve men with a suspicion of PCa was considered.
The Delphi process was carried out in four phases (Fig. 1). (1) Panellists from the European Society of Urogenital Radiology (ESUR) and EAU Section of Urologic Imaging (ESUI) were selected based on expertise and publication record in the PCa diagnosis, and on their involvement in guideline development. (2) A questionnaire was created with items that were identified by a subcommittee of the ESUR, based on the statements from a recent UK consensus paper on implementation of mpMRI for PCa detection [14 (link)]. (3) Panel-based consensus findings were determined using an online Delphi process. For this purpose, an internet survey was generated and sent by email to the members of the group (created in Google Forms). In the second round, a reminder to complete the questionnaires was sent by email. The panellists anonymously completed two rounds of a questionnaire consisting of 39 items (including 55 subquestions). Based on the knowledge of the entire group’s responses in the first round, second round voting was performed. Outcomes of the multiple-choice and open questions were graphically displayed, so the results could be reflected before selecting a response in the second round. For inclusion in the final recommendations, each survey item required to have reached group consensus by the end of the two survey rounds. (4) The items of the questionnaires were analysed, and consensus statements were formulated based on the outcomes. In total, 31 of 55 items were rated for agreement on a 9-point Likert scale.

Details of the stages of the Delphi process (flow chart)

An item scored as ‘agree’ (score 7–9) by ≥ 70% of participants and disagree (score 1–3) by ≤ 15% constituted ‘consensus agreement’ for an item. An item scored as ‘disagree’ (score 1–3) by ≥ 70% of participants and agree (score 7–9) by ≤ 15% was considered as ‘consensus disagreement’. The other items (24 of 55) were multiple-choice or open questions and were presented graphically. For the multiple-choice or open questions to reach consensus, a panel majority scoring of ≥ 50% was required.
Full text: Click here
Publication 2020
Biopsy Diagnosis Europeans Multiparametric Magnetic Resonance Imaging Radiography System, Genitourinary

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Biopsy Core Needle Biopsy Diagnosis Diffusion Heart Human Body Magnetic Resonance Spectroscopy Metals Multiparametric Magnetic Resonance Imaging Pathologists Patients Pelvis Prostate Prostate Cancer Prosthesis System, Genitourinary Tests, Diagnostic X-Rays, Diagnostic

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Brain Brain Neoplasms Genetic Heterogeneity Genome Glioblastoma Multiforme Glioma Inversion, Chromosome Malignant Neoplasms MRI Scans Multiparametric Magnetic Resonance Imaging Neoplasms Patients Radiologist Radionuclide Imaging
Prior to biopsy, an MP-MRI was interpreted by the radiologists; the images were segmented, and lesion locations were recorded (DynaCAD, Invivo). Patients with lesions identified on MP-MRI underwent a targeted biopsy performed by one physician followed in the same session by a standard biopsy performed by another physician who was not aware of the MR lesion locations. Using the UroNav MR/ultrasound fusion device (Invivo), or research iterations of the same device predating the commercially available device, the targeted biopsy was performed with the previously identified MP-MRI lesions superimposed using the T2-weighted sequence on the realtime TRUS images. Each lesion was sampled both in axial and sagittal planes by an end-fire TRUS probe (Philips). The standard biopsy was typically 12 cores collected in an extended-sextant template of biopsies from the lateral and medial aspects of the base, mid, and apical prostate on the left and right side. Only the TRUS images, with no MP-MRI target data available, were used for the standard biopsy portion of the case. More biopsy cores were obtained as part of the standard biopsy if any abnormality was noted on ultrasound. The median time from MP-MRI to biopsy was 43 days (interquartile range, 13-89 days). One genitourinary pathologist (M.J.M.) reviewed all pathologic specimens. The steps in performing an MR/ultrasound fusion biopsy are outlined in Figure 1.
Publication 2015
Biopsy Medical Devices Multiparametric Magnetic Resonance Imaging Pathologists Patients Physicians Prostate Radiologist System, Genitourinary Ultrasonics
All patients underwent MP-MRI on a 3.0-T MRI (Achieva, Philips Healthcare) with 4 sequences–triplanar T2-weighted, dynamic contrast-enhanced, diffusion-weighted imaging, and MR spectroscopy–according to previously published protocols.17 (link) Images were acquired with a 16-channel surface coil (SENSE, Philips Healthcare) and an endorectal coil (BPX-30, Medrad) in most cases or just a surface coil in a few patients. These MP-MRI studies underwent blinded, centralized radiologic evaluation, and lesions were assigned suspicion scores of low, moderate, or high. These scores are based on findings on each MP-MRI sequence using previously described criteria13 and have been associated with both the presence of prostate cancer and tumor grade6 (link),18 (link) (eMethods and eTable 1 in the Supplement). The now standardized PI-RADS criteria19 (link) were not in use at our center during the time frame of this study. Two highly experienced genitourinary radiologists (B.T. and P.L.C.) with 8 and 14 years of experience interpreting prostate MP-MRI performed independent review and formed consensus reads of all studies in this series.
Publication 2015
Dietary Supplements Diffusion Magnetic Resonance Spectroscopy Multiparametric Magnetic Resonance Imaging Neoplasms Patients Prostate Prostate Cancer Radiologist Reading Frames RRAD protein, human System, Genitourinary

Most recents protocols related to «Multiparametric Magnetic Resonance Imaging»

Data were reported as medians, interquartile ranges (IQRs) and frequencies. A correlation between PI-RADS 3 lesions on mpMRI and fusion-TB results as in a per-lesion analysis was made. The diagnostic performance was evaluated using sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). The Mann–Whitney U test was used. The AUC was computed together with the 95% confidence interval (95% CI) and the asymptotic test for null hypothesis: true area=0.5. The best cut-off was calculated using maximisation of the Youden Index. Univariate and multivariate analyses were carried out using logistic regression. Odd ratios (ORs) were calculated together with their 95% CIs. The forward stepwise likelihood ratio method was used for variable selection in the multivariate analysis. The AUC was computed to evaluate the predictive accuracy of the multivariate model. All the tests were 2-tailed, and a p value of <0.05 was considered statistically significant. All the statistical analyses were carried out using IBM SPSS 25.0 (SPSS Inc., Armonk, NY, USA).
Full text: Click here
Publication 2023
Diagnosis Hypersensitivity Multiparametric Magnetic Resonance Imaging RRAD protein, human
All the PI-RADS 3 lesions were biopsied transrectally by two experienced radiologists, who usually read at least 400 mpMRI per year, using the mpMRI-TRUS Fusion image guide feature of “Aplio™ 500 ultrasound system”, after antibiotic prophylaxis and a cleansing rectal enema, using a non-disposable biopsy gun (Medgun, Medax, Modena, Italy) with a disposable 18-gauge needle and a US platform (Canon-Toshiba Aplio 500™, Ōtawara, Kanto, Japan) with an end-fire TRUS probe as previously described (10 (link)).
The biopsy samples were analysed by two dedicated genitourinary pathologists who primarily identified the presence or absence of a neoplastic pathology on the samples. Each neoplastic lesion was graded from 1 to 5 according to the International Society of Urological Pathology (ISUP) Grade Group System (GGS) (12 (link)); lesions having a GGS ≥ 2 were considered to be clinically significant.
Full text: Click here
Publication 2023
Antibiotic Prophylaxis Biopsy Enema Multiparametric Magnetic Resonance Imaging Needles Neoplasms Pathologists Radiologist Rectum RRAD protein, human System, Genitourinary Ultrasonics
The mpMRI examinations were carried out using a 1.5T scanner (Signa HDxt; GE Healthcare, USA) and a pelvic phased-array surface coil combined with a disposable endorectal coil.
The multiparametric study of the prostate gland and seminal vesicles included Fast Relaxation Fast Spin Echo (FR-FSE) T2w, DWI (Diffusion Weighted Imaging) and Dynamic Contrast-Enhanced (DCE) sequences; the scan parameters have already been described in a previous study (9 (link)).
The DWI and DCE images were processed on an independent workstation with dedicated software (Functool, 4.5.5, GE Healthcare, USA) in order to obtain the ADC (Apparent Diffusion Coefficient) map and signal intensity-time (I-T) curve, respectively.
All the PI-RADS 3 lesions were catalogued according to location (peripheral or transition zone) and maximum diameter.
Subsequently, the following parameters were measured on axial FR-FSE T2w sequences as previously described (11 (link)): 1) TransPA, 2) TransCGA, 3) TransPZA, and 4) TransPAI (Figure 2).
The prostate maximum sectional areas on the axial FSE T2w sequences were selected as follows; when the bilateral prostate lobes were basically symmetrical, and the quasi-circular internal urethral sphincter could be seen in the middle of the prostate, the maximum section was that in which the sectional area became smaller when scanning upward or downward.
The contouring of the total prostate area (TransPA) and the central gland area (TransCGA) were manually defined on this selected image; the peripheral zone area (TransPZA) was subsequently calculated.
Full text: Click here
Publication 2023
Diffusion ECHO protocol Internal Urethral Sphincters Multiparametric Magnetic Resonance Imaging Pelvis Physical Examination Prostate Reticulate acropigmentation of Dohi Seminal Vesicles Vision
This study was an observational, retrospective, single centre study; it was approved by our local Institutional Review Board (IRB), which waived the need for informed consent, and conducted in accordance with institutional guidelines, including the Declaration of Helsinki (Ethics Committee code: 784/2021/Oss/AOUBo).
One hundred forty patients with at least one PI-RADS 3 lesion, according to the ESUR guidelines version 2.1 at mpMRI performed at our Radiology Unit from September 2019 to December 2021 were enrolled.
The inclusion criteria were the following: 1) having undergone fusion-TB of the index lesion at our Radiology Unit and 2) having a histopathological report from a dedicated pathologist of the Pathology Unit of our institution.
The exclusion criteria were the following: 1) no concomitant PI-RADS 4 or 5 lesions; 2) mpMRI protocol not completely adhering to the suggested imaging protocols described in PI-RADS version 2.1; 3) active surveillance and previous surgical treatment, such as open simple prostatectomy (OP) or transurethral resection of the prostate (TURP); 4) the presence of severe artifacts, not allowing the evaluation of one or more sequences of the mpMRI due to uni/bilateral hip prostheses or other causes.
After application of the exclusion criteria, 120 patients were included in the final analysis (Figure 1).
For each patient enrolled, clinical data, such as PSA, prostate volume, and PSA density, were collected.
Full text: Click here
Publication 2023
Ethics Committees Ethics Committees, Research Multiparametric Magnetic Resonance Imaging Operative Surgical Procedures Pathologists Patients Prostate Prostatectomy Prostheses, Hip RRAD protein, human Transurethral Resection of Prostate X-Rays, Diagnostic

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Administrative Personnel Biopsy Diagnosis Ethics Committees, Research Malignant Neoplasms Multiparametric Magnetic Resonance Imaging Neoplasm Metastasis Patients Prognosis Prostate Prostate-Specific Antigen Prostate Cancer Therapeutics X-Rays, Diagnostic

Top products related to «Multiparametric Magnetic Resonance Imaging»

Sourced in Netherlands, Germany, United States, United Kingdom, Japan
The Philips Achieva is a versatile laboratory equipment designed for a range of analytical and research applications. It offers advanced capabilities for tasks such as sample preparation, separation, and detection. The Achieva is engineered to provide reliable and consistent performance, making it a valuable tool for various scientific disciplines.
Sourced in United States
The BPX-30 is a versatile laboratory equipment designed for a variety of analytical applications. It features a precise temperature control system and a durable construction to ensure reliable performance. The core function of the BPX-30 is to facilitate sample preparation and analysis tasks in a laboratory environment.
Sourced in Netherlands, Germany, United States, Switzerland, Japan
The Philips Ingenia is a magnetic resonance imaging (MRI) system designed for diagnostic imaging. It provides high-quality images of the body's internal structures to aid in the detection and diagnosis of various medical conditions.
Sourced in Germany, United States
The MAGNETOM Skyra is a magnetic resonance imaging (MRI) system developed by Siemens. It is designed to provide high-quality imaging for various medical applications. The MAGNETOM Skyra utilizes advanced technology to generate detailed images of the body's internal structures without the use of ionizing radiation.
Sourced in Germany, United States, United Kingdom
The Magnetom Trio is a magnetic resonance imaging (MRI) system manufactured by Siemens. It is designed to produce high-quality images of the body's internal structures. The Magnetom Trio uses a powerful superconducting magnet to generate a strong magnetic field, which, in combination with radio waves, allows for the detailed visualization of the body's anatomy and physiology.
Sourced in France, Germany, United States, United Kingdom, Italy
Dotarem is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) procedures. It is designed to enhance the visualization of internal body structures during MRI scans.
Sourced in Germany, United States
Buscopan is a pharmaceutical product developed by Boehringer Ingelheim. It contains the active ingredient hyoscine butylbromide, which acts as an antispasmodic agent.
Sourced in Germany, United States, United Kingdom, China
The Tim Trio is a versatile laboratory equipment that serves as a temperature-controlled magnetic stirrer. It features three independent stirring positions, allowing simultaneous operation of multiple samples. The device maintains a consistent temperature range to ensure accurate and reliable results during experimental procedures.
Sourced in Netherlands, Germany, United States, France
The Achieva 3.0T TX is a magnetic resonance imaging (MRI) system produced by Philips. It is a 3.0 Tesla (T) superconducting magnet-based MRI scanner designed for high-performance imaging.
Sourced in United States, United Kingdom, Germany, Japan, France
The Signa HDxt is a magnetic resonance imaging (MRI) system developed by GE Healthcare. It is designed to provide high-quality, high-resolution medical images for diagnostic purposes. The core function of the Signa HDxt is to generate detailed images of the body's internal structures using strong magnetic fields and radio waves.

More about "Multiparametric Magnetic Resonance Imaging"

Multiparametric Magnetic Resonance Imaging (mpMRI), also known as multimodal MRI or combined MRI, is an advanced imaging technique that integrates multiple MRI modalities to provide a comprehensive assessment of anatomical and functional characteristics of tissues.
This powerful, non-invasive approach enables detailed evaluation of various parameters, including proton density, T1 and T2 relaxation times, diffusion, perfusion, and metabolic information. mpMRI has emerged as a versatile diagnostic tool, widely used for the detection, diagnosis, and monitoring of a variety of medical conditions, such as cancer, neurodegenerative disorders, and cardiovascular disease.
By combining complementary MRI data, mpMRI can enhance diagnostic accuracy, improve treatment planning, and facilitate earlier disease detection.
This cutting-edge imaging method continues to evolve, offering new insights and opportunities for clinicians and researchers to advance patient care.
Technlogies like Achieva, BPX-30, Ingenia, MAGNETOM Skyra, Magnetom Trio, Dotarem, Buscopan, Tim Trio, and Achieva 3.0T TX play a crucial role in enabling high-quality mpMRI scans and analyses.
With its ability to provide a comprehensive understanding of tissue characteristics, mpMRI has become an indispensable tool in the field of medical imaging, revolutionizing the way healthcare professionals approach disease diagnosis and management.
As the technology continues to progress, the potential for mpMRI to transform patient outcomes and advance the frontiers of medical research remains immense.